Medy-Tox Inc. (KOSDAQ:086900)
South Korea · Delayed Price · Currency is KRW 77,300
-700 (-0.90%)
Aug 12, 2026, 3:30 PM KST
Medy-Tox Market Cap
Medy-Tox has a market cap or net worth of 508.37 billion as of August 11, 2026. Its market cap has decreased by -44.38% in one year.
Market Cap
508.37B
Enterprise Value
596.20B
Revenue
244.02B
Ranking
n/a
PE Ratio
23.84
Stock Price
77,300.00
ChartMarket Cap Chart
Since January 16, 2009, Medy-Tox's market cap has increased from 71.73B to 508.37B, an increase of 608.77%. That is a compound annual growth rate of 11.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 508.37B | -40.05% |
| Dec 30, 2025 | 847.99B | 2.03% |
| Dec 30, 2024 | 831.10B | -48.75% |
| Dec 28, 2023 | 1.62T | 101.16% |
| Dec 29, 2022 | 806.18B | -7.99% |
| Dec 30, 2021 | 876.20B | -13.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chabiotech | 860.27B |
| Pharmicell | 671.44B |
| Hyundai Bioscience | 655.26B |
| Onconic Therapeutics | 637.98B |
| AbClon | 558.66B |
| GI Innovation | 551.61B |
| GC Corp. | 468.09B |
| MEDIPOST | 384.99B |